DoD Peer Reviewed Medical Technology/Therapeutic Development Award | Apply Online

FAQs: DoD PRMRP Technology/Therapeutic Development Award (W81XWH 16 PRMRP TTDA)

What is the DoD PRMRP Technology/Therapeutic Development Award?

It is a Department of Defense (DoD) funding opportunity under the Peer Reviewed Medical Research Program (PRMRP) designed to move promising preclinical medical research toward a real-world medical product that can be used in clinical settings. The focus is on product-driven translation rather than basic discovery.

What is the main goal of this award mechanism?

The central purpose is to accelerate development of tangible medical technologies or therapeutics by supporting the transition from strong preclinical evidence into development steps that position a product for clinical use, with the intent to contribute to prevention, detection, diagnosis, treatment, or improvements in quality of life.

Does this award support basic research or discovery?

No. The mechanism is described as not supporting basic discovery work. It is intended for product-driven translation, meaning the proposed work should advance a candidate technology or therapy along a development pathway toward clinical applicability.

What kind of projects are a fit for this opportunity?

Projects are a fit when they are focused on advancing a candidate medical technology or therapeutic from promising preclinical findings into development activities that make it realistic to become a clinical product. The emphasis is on moving toward something usable in clinical settings, rather than generating early-stage foundational knowledge.

What populations or mission needs should the project address?

The opportunity emphasizes healthcare needs relevant to military Service members, Veterans, and/or other eligible beneficiaries. Applicants were expected to clearly connect the product's intended use and impact to the needs and realities of these populations, not solely to general civilian healthcare priorities.

Is alignment with specific PRMRP topic areas required?

Yes. A key requirement is that the proposed product aligns with at least one of the Congressionally directed FY2016 PRMRP Topic Areas.

What is the official title of the opportunity?

The opportunity was released under the title "DoD Peer Reviewed Medical Technology/Therapeutic Development Award".

What is the funding opportunity number?

The funding opportunity number is W81XWH 16 PRMRP TTDA.

Who administered this funding opportunity?

It was administered by DOD-AMRAA, the U.S. Army Medical Research Acquisition Activity.

What funding activity category does this opportunity fall under?

It fell under the Science and Technology and other Research and Development funding activity category.

What CFDA number is associated with this opportunity?

The opportunity is associated with CFDA 12.420, which is commonly used for DoD medical research assistance programs.

Who was eligible to apply?

Eligibility was listed as unrestricted, meaning it was broadly open to many types of applicants (such as academic institutions, nonprofits, for-profits, and other organizations). Any additional eligibility clarifications would have been specified in the full announcement.

What types of award instruments were available?

The opportunity allowed for both grants and cooperative agreements. This indicates some awards could involve more collaboration or active management by the DoD than a standard grant, depending on the project and the government's involvement needs.

What is the difference between a grant and a cooperative agreement in this listing?

Based on the listing, both instruments were possible. The key distinction noted is that cooperative agreements can involve a more collaborative or actively managed relationship with the DoD compared with a standard grant, depending on the project and the level of government involvement required.

When was this opportunity posted?

The timeline information indicates it was posted and created on May 5, 2016.

What was the application deadline?

The original and current application closing date shown is October 19, 2016.

How many awards were expected to be made?

The listing anticipated making around 10 awards.

What was the maximum award amount (award ceiling)?

The award ceiling field is shown but not populated in the provided data, so the maximum award amount cannot be confirmed from the excerpt alone.

What is the key theme reviewers likely looked for based on the description?

The description repeatedly emphasizes translation to a tangible product and military/Veteran health relevance. Based on the provided information, a strong application would be expected to clearly show a development pathway from preclinical evidence toward clinical use and explain why the product matters for Service members, Veterans, and/or other eligible beneficiaries.

Is this opportunity intended to fund something that can be used in a clinical setting?

Yes. The program is explicitly focused on moving promising preclinical work toward medical products that can be used in clinical settings.

Does the opportunity require the project to be product-driven?

Yes. The mechanism is described as designed for product-driven translation, meaning the emphasis is on advancing a candidate technology or therapy along a development pathway toward real-world use.